Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Amneal Pharmaceuticals Community
NasdaqGS:AMRX Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Amneal Pharmaceuticals
Popular
Undervalued
Overvalued
Amneal Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Global Health Trends And Pipeline Launches Will Fuel Future Potential
Key Takeaways Diversification into branded, complex products and biosimilars, along with global expansion and partnerships, positions the company for continued revenue and profit growth. Investments in manufacturing, supply chain optimization, and improved financial flexibility strengthen operational resilience and support margin improvement amid shifting healthcare dynamics.
View narrative
US$12.00
FV
26.3% undervalued
intrinsic discount
7.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
AMRX
AMRX
Amneal Pharmaceuticals
Your Fair Value
US$
Current Price
US$8.84
4.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-194m
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$4.1b
Earnings US$4.8m
Advanced
Set Fair Value